Ligand-independent HER2/HER3/PI3K complex is disrupted by trastuzumab and is effectively inhibited by the PI3K inhibitor GDC-0941 - Junttila, T T; Akita, R W; Parsons, K (Cancer Cell, 2009)
et al.